Ultrasound-enhanced transdermal delivery: recent advances and future challenges - Test2 - elhamkhani - TriplyDB

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

http://www.wikidata.org/entity/Q26829601

about

Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting Identifying present challenges to reliable future transdermal drug delivery products.Glucose Sensing for Diabetes Monitoring: Recent Developments.Differential effects on membrane permeability and viability of human keratinocyte cells undergoing very low intensity megasonic fields.Ultrasound-Enhanced Drug Delivery for Treatment of Onychomycosis.A future perspective for regenerative medicine: understanding the concept of vibrational medicine.Ultrasound-Mediated EGF-Coated-Microbubble Cavitation in Dressings for Wound-Healing Applications.

P2860

Q28079462-4E34D7F0-347D-491D-8BA3-42191BCCF19E Q38595263-F7C40B0F-A8F8-4AF0-8DA5-4C8482DA2A79 Q38626127-FC2A1DA4-CF63-4348-A4F2-192B5EA588B9 Q47139913-4696CA12-2E70-449F-A80B-315F67FAB5BF Q47210309-6AB99481-C349-4217-83AD-7CB9611F92E2 Q51760385-163B5173-7F73-41F5-8361-5CC06D7FBB07 Q55019934-9ADFE7C6-D819-4D52-8743-34C6E57E8C97

P2860

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

http://www.wikidata.org/entity/Q26829601

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@ast

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@en

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@nl

type

label

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@ast

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@en

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@nl

prefLabel

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@ast

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@en

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@nl

P1433

Q26829601-65C4B42D-B9B2-4861-80BA-FCD0DC23FD5C

P1476

Q26829601-4249F428-1B52-4442-BF4A-E8A20F8994A3

P2093

Q26829601-5D143A38-7C76-4BBE-8FF4-634537397242

Q26829601-7D8FFD38-A3CB-40F0-9B32-0F99C674DEB4

Q26829601-F46C3DE7-C06A-4E93-9CB1-98FBE586C4A6

P2860

Q26829601-096EBACB-3959-483C-85F9-C98F75E45E4A

Q26829601-0B0C3F93-0799-46B4-95E3-2B82F9B451CA

Q26829601-0CB05875-6B27-4EF4-AB5C-EBAE747FC07C

Q26829601-1122A125-D0E2-4B46-AD67-7BF565232274

Q26829601-112A8153-5843-4693-9A44-129AD7766D08

Q26829601-13FF89BD-E4B5-4F04-B06F-20B68B437F30

Q26829601-24623AE9-1531-4940-9AE2-0496DD021851

Q26829601-2B841C13-2D10-451F-BDF8-B6AED8DAAA77

Q26829601-2ECA1D64-5846-411A-916A-449D24DC14B5

Q26829601-3717B4E6-27AB-4426-9FA7-15C8D72B5C54

P304

Q26829601-4F99E24E-3588-4725-8338-AF0954F5F50D

P31

Q26829601-11EA9AFD-915A-4A08-827E-CEEA175E86E9

P356

Q26829601-F2BFC0C9-E9EC-47A6-8BFB-958315952322

P407

Q26829601-B4F3CA9B-580B-4284-BB2C-D92FED53B966

P433

Q26829601-C966B1AB-9D5D-46AE-8158-B6BF60445434

P478

Q26829601-7852A194-EB35-42A1-A1B1-70EDD04B693B

P50

Q26829601-3A021CDD-631C-4406-947D-1DD9084991B7

Q26829601-7953A9AE-D76B-4E83-914F-3C4E24530FF3

P577

Q26829601-EB2B7888-C58A-48E6-8261-EBDDE45C29DB

P5875

Q26829601-045ABD28-47D2-42A8-B829-29B2D4300A81

P698

Q26829601-11D8C487-5051-4983-9FB5-1D3D78F9B715

P932

Q26829601-BB5FB4EF-0549-46F9-95EA-58D09615B977

P356

P1433

Therapeutic delivery

P1476

Ultrasound-enhanced transdermal delivery: recent advances and future challenges

@en

P2093

Daniel Blankschtein

http://www.w3.org/2001/XMLSchema#string

Matthias A Oberli

http://www.w3.org/2001/XMLSchema#string

Robert Langer

http://www.w3.org/2001/XMLSchema#string

P2860

Microbubble contrast agents: a new era in ultrasound

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

The 500 Dalton rule for the skin penetration of chemical compounds and drugs

Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.

Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes

Current status and future potential of transdermal drug delivery

Finite element static displacement optimization of 20-100 kHz flexural transducers for fully portable ultrasound applicator

Rapid skin permeabilization by the simultaneous application of dual-frequency, high-intensity ultrasound.

Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends

Optimization of un-tethered, low voltage, 20-100kHz flexural transducers for biomedical ultrasonics applications

P304

843-857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE.14.32

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Carl M. Schoellhammer

Robert Samuel Langer, Jr.

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266623491

http://www.w3.org/2001/XMLSchema#string

P698

25287389

http://www.w3.org/2001/XMLSchema#string

P932

4725305

http://www.w3.org/2001/XMLSchema#string